CIG
DXCM icon

Cullen Investment Group’s DexCom DXCM Stock Holding History

Cullen Investment Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,164
Closed -$1.02M – 179
2025
Q3 		$1.02M Buy
15,164
+927
+7% +$73.4K 0.13% 98
2025
Q2 		$1.24M Buy
14,237
+1,432
+11% +$112K 0.18% 89
2025
Q1 		$874K Buy
12,805
+1,303
+11% +$106K 0.13% 109
2024
Q4 		$895K Buy
11,502
+614
+6% +$45.5K 0.13% 112
2024
Q3 		$730K Buy
10,888
+454
+4% +$37.3K 0.11% 123
2024
Q2 		$1.18M Buy
10,434
+562
+6% +$71.1K 0.19% 93
2024
Q1 		$1.35M Buy
+9,872
New +$1.24M 0.21% 90

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cullen Investment Group's DXCM Position: Q4 2025 in Review

Cullen Investment Group sold out of DexCom (DXCM) in Q4 2025, closing a stake of 15,164 shares — an estimated $1.02M sold.

Cullen Investment Group first reported a position in DXCM in Q1 2024 and held it in 7 quarters. The position peaked at $1.35M in Q1 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Cullen Investment Group reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Cullen Investment Group sold 15,164 DexCom shares in Q4 2025, an estimated $1.02M.
  • Cullen Investment Group first reported a position in DexCom in Q1 2024 and held it in 7 quarters.
  • Cullen Investment Group's DexCom position peaked at $1.35M in Q1 2024.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Cullen Investment Group's 13F filing for Q4 2025, filed 12 Jan 2026.